203 related articles for article (PubMed ID: 31572339)
1. Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages.
Delves M; Lafuente-Monasterio MJ; Upton L; Ruecker A; Leroy D; Gamo FJ; Sinden R
Front Microbiol; 2019; 10():2134. PubMed ID: 31572339
[TBL] [Abstract][Full Text] [Related]
2. A randomized feasibility trial comparing four antimalarial drug regimens to induce
Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
Elife; 2018 Feb; 7():. PubMed ID: 29482720
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase inhibitors BVT-948 and alexidine dihydrochloride inhibit sexual development of the malaria parasite Plasmodium berghei.
Jia X; Liu F; Bai J; Zhang Y; Cui L; Cao Y; Luo E
Int J Parasitol Drugs Drug Resist; 2022 Aug; 19():81-88. PubMed ID: 35792443
[TBL] [Abstract][Full Text] [Related]
4. A conserved malaria parasite antigen Pb22 plays a critical role in male gametogenesis in Plasmodium berghei.
Liu F; Yang F; Wang Y; Hong M; Zheng W; Min H; Li D; Jin Y; Tsuboi T; Cui L; Cao Y
Cell Microbiol; 2021 Mar; 23(3):e13294. PubMed ID: 33222390
[TBL] [Abstract][Full Text] [Related]
5. A Malaria Transmission-Blocking (+)-Usnic Acid Derivative Prevents Plasmodium Zygote-to-Ookinete Maturation in the Mosquito Midgut.
Pastrana-Mena R; Mathias DK; Delves M; Rajaram K; King JG; Yee R; Trucchi B; Verotta L; Dinglasan RR
ACS Chem Biol; 2016 Dec; 11(12):3461-3472. PubMed ID: 27978709
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
Zheng W; Liu F; He Y; Liu Q; Humphreys GB; Tsuboi T; Fan Q; Luo E; Cao Y; Cui L
Parasit Vectors; 2017 Jan; 10(1):8. PubMed ID: 28057055
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.
Wang J; Zheng W; Liu F; Wang Y; He Y; Zheng L; Fan Q; Luo E; Cao Y; Cui L
Malar J; 2017 Nov; 16(1):458. PubMed ID: 29132428
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
[TBL] [Abstract][Full Text] [Related]
9. Functional Conservation of P48/45 Proteins in the Transmission Stages of
Cao Y; Hart RJ; Bansal GP; Kumar N
mBio; 2018 Sep; 9(5):. PubMed ID: 30181253
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.
D'Alessandro S; Corbett Y; Ilboudo DP; Misiano P; Dahiya N; Abay SM; Habluetzel A; Grande R; Gismondo MR; Dechering KJ; Koolen KM; Sauerwein RW; Taramelli D; Basilico N; Parapini S
Antimicrob Agents Chemother; 2015 Sep; 59(9):5135-44. PubMed ID: 26055362
[TBL] [Abstract][Full Text] [Related]
11. Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening.
Fabbri C; Trindade AO; Andrade FS; Souza MF; Ríos-Velásquez CM; Lacerda MVG; Monteiro WM; Costa FTM; Amino R; Lopes SCP
Mem Inst Oswaldo Cruz; 2021; 116():e200513. PubMed ID: 33566952
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X.
Li F; Bounkeua V; Pettersen K; Vinetz JM
Malar J; 2016 Feb; 15():111. PubMed ID: 26911483
[TBL] [Abstract][Full Text] [Related]
13. The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
Sala KA; Nishiura H; Upton LM; Zakutansky SE; Delves MJ; Iyori M; Mizutani M; Sinden RE; Yoshida S; Blagborough AM
Vaccine; 2015 Jan; 33(3):437-45. PubMed ID: 25454088
[TBL] [Abstract][Full Text] [Related]
14. Identification of Three Novel
Ukegbu CV; Christophides GK; Vlachou D
Front Cell Infect Microbiol; 2021; 11():634273. PubMed ID: 33791240
[No Abstract] [Full Text] [Related]
15. Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds.
Abay SM; Lucantoni L; Dahiya N; Dori G; Dembo EG; Esposito F; Lupidi G; Ogboi S; Ouédraogo RK; Sinisi A; Taglialatela-Scafati O; Yerbanga RS; Bramucci M; Quassinti L; Ouédraogo JB; Christophides G; Habluetzel A
Malar J; 2015 Jul; 14():288. PubMed ID: 26208861
[TBL] [Abstract][Full Text] [Related]
16. Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes.
Paonessa G; Siciliano G; Graziani R; Lalli C; Cecchetti O; Alli C; La Valle R; Petrocchi A; Sferrazza A; Bisbocci M; Falchi M; Toniatti C; Bresciani A; Alano P
Commun Biol; 2022 Jun; 5(1):547. PubMed ID: 35668202
[TBL] [Abstract][Full Text] [Related]
17. Additional Feeding Reveals Differences in Immune Recognition and Growth of
Kwon H; Simões ML; Reynolds RA; Dimopoulos G; Smith RC
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789941
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Sulfhydryl Oxidase From
Zheng W; Liu F; Du F; Yang F; Kou X; He Y; Feng H; Fan Q; Luo E; Min H; Miao J; Cui L; Cao Y
Front Cell Infect Microbiol; 2020; 10():311. PubMed ID: 32670896
[TBL] [Abstract][Full Text] [Related]
19. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay.
Lelièvre J; Almela MJ; Lozano S; Miguel C; Franco V; Leroy D; Herreros E
PLoS One; 2012; 7(4):e35019. PubMed ID: 22514702
[TBL] [Abstract][Full Text] [Related]
20. Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc.
Calit J; Araújo JE; Deng B; Miura K; Gaitán XA; Araújo MDS; Medeiros JF; Long CA; Simeonov A; Eastman RT; Bargieri DY
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0146522. PubMed ID: 36856421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
